176 related articles for article (PubMed ID: 15855323)
21. Pioglitazone-induced increase in the stearoyl-CoA desaturation index and fat accumulation in rat muscles are not related to lipoprotein lipase activity.
Ochiai M; Matsuo T
J Oleo Sci; 2013; 62(9):745-54. PubMed ID: 24005019
[TBL] [Abstract][Full Text] [Related]
22. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.
Tiikkainen M; Häkkinen AM; Korsheninnikova E; Nyman T; Mäkimattila S; Yki-Järvinen H
Diabetes; 2004 Aug; 53(8):2169-76. PubMed ID: 15277403
[TBL] [Abstract][Full Text] [Related]
23. Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.
Duan SZ; Usher MG; Foley EL; Milstone DS; Brosius FC; Mortensen RM
Diabetologia; 2010 Jul; 53(7):1493-505. PubMed ID: 20401461
[TBL] [Abstract][Full Text] [Related]
24. Interaction of diet and the masou salmon Δ5-desaturase transgene on Δ6-desaturase and stearoyl-CoA desaturase gene expression and N-3 fatty acid level in common carp (Cyprinus carpio).
Cheng Q; Su B; Qin Z; Weng CC; Yin F; Zhou Y; Fobes M; Perera DA; Shang M; Soller F; Shi Z; Davis A; Dunham RA
Transgenic Res; 2014 Oct; 23(5):729-42. PubMed ID: 25011564
[TBL] [Abstract][Full Text] [Related]
25. Effect of troglitazone on the desaturases in a rat model of insulin-resistance induced by a sucrose-rich diet.
Montanaro MA; Lombardo YB; González MS; Bernasconi AM; Chicco A; Rimoldi OJ; Basabe JC; Brenner RR
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):241-50. PubMed ID: 15763435
[TBL] [Abstract][Full Text] [Related]
26. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
[TBL] [Abstract][Full Text] [Related]
28. The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake.
Festuccia WT; Blanchard PG; Turcotte V; Laplante M; Sariahmetoglu M; Brindley DN; Richard D; Deshaies Y
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1327-35. PubMed ID: 19211718
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.
Yilmaz MI; Sonmez A; Caglar K; Gok DE; Eyileten T; Yenicesu M; Acikel C; Bingol N; Kilic S; Oguz Y; Vural A
Endocrine; 2004 Dec; 25(3):207-14. PubMed ID: 15758247
[TBL] [Abstract][Full Text] [Related]
30. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.
Askari B; Kanter JE; Sherrid AM; Golej DL; Bender AT; Liu J; Hsueh WA; Beavo JA; Coleman RA; Bornfeldt KE
Diabetes; 2007 Apr; 56(4):1143-52. PubMed ID: 17259370
[TBL] [Abstract][Full Text] [Related]
32. PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids.
Sauma L; Stenkula KG; Kjølhede P; Strålfors P; Söderström M; Nystrom FH
Nutrition; 2006 Jan; 22(1):60-8. PubMed ID: 16226011
[TBL] [Abstract][Full Text] [Related]
33. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
34. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
35. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men.
Petersson H; Basu S; Cederholm T; Risérus U
Br J Nutr; 2008 Jun; 99(6):1186-9. PubMed ID: 18062827
[TBL] [Abstract][Full Text] [Related]
36. Effects of short- and long-chain fatty acids on the expression of stearoyl-CoA desaturase and other lipogenic genes in bovine mammary epithelial cells.
Jacobs AA; Dijkstra J; Liesman JS; Vandehaar MJ; Lock AL; van Vuuren AM; Hendriks WH; van Baal J
Animal; 2013 Sep; 7(9):1508-16. PubMed ID: 23597233
[TBL] [Abstract][Full Text] [Related]
37. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.
Yang WS; Jeng CY; Wu TJ; Tanaka S; Funahashi T; Matsuzawa Y; Wang JP; Chen CL; Tai TY; Chuang LM
Diabetes Care; 2002 Feb; 25(2):376-80. PubMed ID: 11815513
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study.
Takkunen MJ; Schwab US; de Mello VD; Eriksson JG; Lindström J; Tuomilehto J; Uusitupa MI;
Eur J Nutr; 2016 Apr; 55(3):967-79. PubMed ID: 25930966
[TBL] [Abstract][Full Text] [Related]
39. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
40. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
